EQS-News: Healthcare Triangle Inc.'s Subsidiary QuantumNexis Advances Strategic International Partnerships, Signaling Approximately USD 2M Revenue Opportunity and Global Expansion

PLEASANTON, CALIF. - July 31, 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries - today announced that its wholly owned subsidiary, QuantumNexis, is advancing strategic partnerships in Malaysia. The company estimates these initiatives represent a combined revenue opportunity of approximately USD 2 million, supporting HCTI’s broader international growth strategy.

Just 45 days post-launch, QuantumNexis has secured strategic partnerships with approximately USD 2M revenue upside - underscoring its rapid execution, market fit, and global expansion momentum.

These late-stage partnerships mark a significant milestone in QuantumNexis’s expansion into Southeast Asia and reinforce HCTI’s commitment to delivering AI-driven platforms that address enterprise mental health and digital health innovation in global markets.

The country of Malaysia itself presents a phenomenal, outsized addressable opportunity for HCTI and QuantumNexis given a population of 35.6 million people of which 29% (of those aged 16 or older) experience mental health problems, according to recent surveys.

Confirmed Partnership discussions include:
• A collaboration with V-Sure Tech Sdn Bhd, Malaysia’s only on-demand lifestyle digital insurer, to support mental wellness for small and medium-sized enterprises (SMEs) through a bundled digital offering of QuantumNexis’s GenAI-powered integrative mental health platform (Ziloy).
• An engagement with Malaysia’s leading Third-Party Administrator (TPA), a long-standing provider of healthcare claims management and employee benefits administration, to broaden digital access to QuantumNexis’s GenAI-powered integrative mental health platform (Ziloy) for enterprise populations.

“QuantumNexis is at the forefront of a global shift toward AI-powered digital health,” said Suresh Venkatachari, Chairman of QuantumNexis.

“These strategic partnerships reflect our bold vision to redefine how healthcare is delivered and scaled worldwide. With every market we enter, we’re unlocking new value and setting the standard for what’s next in digital health innovation.”

“These initiatives strongly align with HCTI’s global growth strategy and reflect the growing international appetite for intelligent healthcare solutions,” said Sujatha Ramesh, Chief Operating Officer of Healthcare Triangle, Inc and QuantumNexis.

“We are proud to see QuantumNexis taking the lead in Southeast Asia with trusted partners who share our mission to transform healthcare through our global GenAI-powered platform.”

Dato’ Dr. Emmanuel Benson, Executive Director, along with the leadership team of QuantumNexis Kuala Lumpur, Malaysia, played a critical role in advancing these initiatives and supporting the company’s regional growth trajectory.

HCTI’s subsidiary, QuantumNexis, is also advancing a strong pipeline of late-stage opportunities across Southeast Asia, including:
• NDA-backed discussions with hospital networks and healthcare providers for mental wellness and wound care deployments
• A proposed AI-enabled clinic management system covering 5,000+ clinics under commercial evaluation
• Pilot planning with a licensed psychological rehabilitation group to integrate systems and onboard clinicians

Additional regional opportunities are under evaluation, aligned with HCTI’s continued focus on scaling Gen AI powered healthcare solutions globally.

About Healthcare Triangle

Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the consummation of the private placement, satisfaction of the customary closing conditions of the private placement and the use of the proceeds therefrom. Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, on file with the Securities Exchange Commission (the “SEC”) and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Investors:
1-800-617-9550
ir@healthcaretriangle.com

News Source: Healthcare Triangle